EUVIMEDEUVIMED entdecken
Open Access

Pharmacologic and Adjunct Therapies for Pediatric Gastroenteritis

Chandrika Murugaiah

The Journal of Pediatric Pharmacology and Therapeutics · 2026-08 · 31 (4) · 557-559

DOI: 10.5863/jppt-25-00182 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pediatric Pharmacology and Therapeutics, 2026-08. Verfasst von Chandrika Murugaiah. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Medicine & Dentistry, Manipal University College Malaysia, Melaka, Malaysia. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To the Editor: Acute gastroenteritis remains a leading cause of pediatric morbidity worldwide, frequently resulting in dehydration, vomiting, electrolyte imbalance, and hospitalization.Although mortality has declined, optimal pharmacologic and adjunctive strategies remain clinically important, particularly in children unable to tolerate oral rehydration therapy (ORT).This Research Letter summarizes evidence-based pharmacologic and adjunct therapies for pediatric acute gastroenteritis and provides practical age-and weightbased recommendations for clinical use.[1][2][3][4] A focused literature search of PubMed, Scopus, Cochrane CENTRAL, and major international guidelines was conducted for studies and guidance published from January 2000 through April 2026.Randomized controlled trials, systematic reviews, meta-analyses, and guideline statements evaluating therapies in children aged 0-18 years were prioritized.Outcomes of interest included duration of diarrhea, stool output, vomiting control, ORT success, need for intravenous fluids, hospitalization, and adverse effects.Because trials differed in populations, pathogens, formulations, and outcome definitions, findings were synthesized qualitatively with emphasis on clinically actionable dosing and safety.ORT remains the foundation of treatment.Reducedosmolarity oral rehydration solution should contain approximately glucose 75 mmol/L, sodium 75 mmol/L, potassium 20 mmol/L, chloride 65 mmol/L, citrate 10 mmol/L, and a total osmolarity of 245 mOsm/L.For minimal or no dehydration, caregivers should provide usual age-appropriate fluids and food, and replace fluids after each loose stool: approximately 60 to 120 mL for children weighing less than 10 kg and 120 to 240 mL for children weighing 10 kg or more.For mild to moderate dehydration, ORS should be given at 50 to 100 mL/kg over 2 to 4 hours, then maintenance fluids and ongoing stool-loss replacement should be continued.In children with vomiting, small frequent volumes, such as 5 mL every 1 to 2 minutes by spoon, syringe, or cup, may be advanced as tolerated.1,2

Autor:innen und Institutionen

  • Department of Biochemistry, Faculty of Medicine & Dentistry, Manipal University College Malaysia, Melaka, Malaysia.

Zitieren

APA

Murugaiah, C. (2026). Pharmacologic and Adjunct Therapies for Pediatric Gastroenteritis. The Journal of Pediatric Pharmacology and Therapeutics, 31(4), 557-559. https://doi.org/10.5863/jppt-25-00182

Vancouver

Murugaiah C. Pharmacologic and Adjunct Therapies for Pediatric Gastroenteritis. The Journal of Pediatric Pharmacology and Therapeutics. 2026;31(4):557-559. doi:10.5863/jppt-25-00182

BibTeX
@article{Murugaiah2026,
  author = {Murugaiah, Chandrika},
  title = {Pharmacologic and Adjunct Therapies for Pediatric Gastroenteritis},
  journal = {The Journal of Pediatric Pharmacology and Therapeutics},
  year = {2026},
  volume = {31},
  number = {4},
  pages = {557--559},
  doi = {10.5863/jppt-25-00182}
}
Kostenlos starten →